1. Home
  2. ATAI vs GAU Comparison

ATAI vs GAU Comparison

Compare ATAI & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • GAU
  • Stock Information
  • Founded
  • ATAI 2018
  • GAU 1999
  • Country
  • ATAI Germany
  • GAU Canada
  • Employees
  • ATAI N/A
  • GAU N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • GAU
  • Sector
  • ATAI Health Care
  • GAU
  • Exchange
  • ATAI Nasdaq
  • GAU Nasdaq
  • Market Cap
  • ATAI 280.2M
  • GAU 323.9M
  • IPO Year
  • ATAI 2021
  • GAU N/A
  • Fundamental
  • Price
  • ATAI $1.99
  • GAU $1.31
  • Analyst Decision
  • ATAI Strong Buy
  • GAU Strong Buy
  • Analyst Count
  • ATAI 4
  • GAU 2
  • Target Price
  • ATAI $9.00
  • GAU $2.53
  • AVG Volume (30 Days)
  • ATAI 4.9M
  • GAU 829.0K
  • Earning Date
  • ATAI 03-27-2025
  • GAU 03-04-2025
  • Dividend Yield
  • ATAI N/A
  • GAU N/A
  • EPS Growth
  • ATAI N/A
  • GAU N/A
  • EPS
  • ATAI N/A
  • GAU N/A
  • Revenue
  • ATAI $331,000.00
  • GAU $166,788,000.00
  • Revenue This Year
  • ATAI $80.07
  • GAU N/A
  • Revenue Next Year
  • ATAI N/A
  • GAU $44.80
  • P/E Ratio
  • ATAI N/A
  • GAU N/A
  • Revenue Growth
  • ATAI N/A
  • GAU N/A
  • 52 Week Low
  • ATAI $1.03
  • GAU $0.89
  • 52 Week High
  • ATAI $2.85
  • GAU $2.00
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 51.96
  • GAU 59.31
  • Support Level
  • ATAI $1.94
  • GAU $1.17
  • Resistance Level
  • ATAI $2.16
  • GAU $1.35
  • Average True Range (ATR)
  • ATAI 0.34
  • GAU 0.06
  • MACD
  • ATAI -0.03
  • GAU 0.02
  • Stochastic Oscillator
  • ATAI 48.38
  • GAU 78.57

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About GAU Galiano Gold Inc.

Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages the Asanko Gold Mine, located in Ghana, West Africa. Its Asanko Gold Mine is a multi-deposit complex, with two main deposits, the Obotan Project and the Esaase Project, both located in the Amansie West District of the Republic of Ghana, West Africa.

Share on Social Networks: